The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.

The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.
复制标题

DOI:
10.1053/j.seminoncol.2012.02.006
复制
发表时间:
2012-06
影响因子:
4
通讯作者:
Gameiro SR
Gameiro SR
中科院分区:
医学3区
文献类型:
--
作者:
Hodge JW;Ardiani A;Farsaci B;Kwilas AR;Gameiro SR

文献摘要

参考文献

被引文献

相似文献

治疗性癌症疫苗是一种独特的治疗方式,因为它们启动激活宿主免疫系统的动态过程,然后可以通过同时或后续治疗来利用。将免疫疗法添加到标准护理癌症疗法中已经在临床前模型和临床环境中显示出疗效的证据。本文综述了疫苗介导的肿瘤特异性免疫应答与局部放疗、全身化疗或选择性小分子抑制剂之间的临床前和临床相互作用,以及这些方式之间的潜在协同作用。
Therapeutic cancer vaccines are a unique treatment modality in that they initiate a dynamic process of activating the host immune system, which can then be exploited by concurrent or subsequent therapies. The addition of immunotherapy to standard-of-care cancer therapies has shown evidence of efficacy in preclinical models and in the clinical setting. This review examines the preclinical and clinical interactions between vaccine-mediated tumor-specific immune responses and local radiation, systemic chemotherapy, or select small-molecule inhibitors, as well as the potential synergy between these modalities.
DOI: 10.1038/onc.2009.52
发表时间: 2008-12
期刊: Oncogene
影响因子: 8
作者:
Ni Chonghaile T;Letai A
通讯作者: Letai A
DOI: 10.1084/jem.20050915
发表时间: 2005-12-19
期刊: The Journal of experimental medicine
影响因子: --
作者:
Casares N;Pequignot MO;Tesniere A;Ghiringhelli F;Roux S;Chaput N;Schmitt E;Hamai A;Hervas-Stubbs S;Obeid M;Coutant F;Métivier D;Pichard E;Aucouturier P;Pierron G;Garrido C;Zitvogel L;Kroemer G
通讯作者: Kroemer G
DOI: 10.1038/nrc1323
发表时间: 2004-04-01
影响因子: 78.5
作者:
Bartlett, JB;Dredge, K;Dalgleish, AG
通讯作者: Dalgleish, AG
DOI: 10.1007/s00262-009-0706-7
发表时间: 2009-07-01
影响因子: 5.8
作者:
Asemissen, Anne Marie;Brossart, Peter
通讯作者: Brossart, Peter
DOI: 10.1158/1078-0432.ccr-05-2059
发表时间: 2006-02-15
影响因子: 11.5
作者:
Arlen, PM;Gulley, JL;Dahut, W
通讯作者: Dahut, W